SCHEMBL6298086

SCHEMBL6298086

COC(COc1cccc2c(OCC(OC)OC)cccc12)OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR2E1 Q9Y466 6/20 0.46
CYP1A2 P05177 5/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP2D6 P10635 4/20 0.41
ADRB2 P07550 4/20 0.41
ADRB1 P08588 4/20 0.41
SIGMAR1 Q99720 4/20 0.41
SLC6A4 P31645 3/20 0.41
HTR2B P41595 3/20 0.41
ALDH1A1 P00352 3/20 0.41
ADRB3 P13945 3/20 0.41
HTR2A P28223 3/20 0.41
HTR2C P28335 3/20 0.41
HTR6 P50406 3/20 0.41
LMNA P02545 3/20 0.41
TSHR P16473 3/20 0.41
SCN1A P35498 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14477157 0.89 NR2E1 (0.60) NR2E1CYP1A2KDM4EMEN1CYP2C19
SCHEMBL9336777 0.79 HTR1B (0.50) CYP1A2KDM4EMEN1KMT2AALDH1A1
SCHEMBL19683357 0.78 NR2E1 (0.44) NR2E1CYP1A2KDM4EMEN1CYP2C19
SCHEMBL6663577 0.78 ALOX15 (0.53) CYP1A2KDM4ECYP2C19CYP2D6ALDH1A1
SCHEMBL31040026 0.77 LMNA (0.45) CYP1A2KDM4EMEN1KMT2AALDH1A1
SCHEMBL28273569 0.77 L3MBTL1 (0.39) CYP1A2KDM4EMEN1KMT2ASLC6A4
SCHEMBL7694021 0.76 KMT2A (0.49) CYP1A2MEN1CYP2C19KMT2AALDH1A1
SCHEMBL31345547 0.76 CYP1A2 (0.40) NR2E1CYP1A2KDM4EADRB2ADRB1
SCHEMBL31040058 0.74 L3MBTL1 (0.37) NR2E1CYP1A2KDM4EMEN1KMT2A
SCHEMBL19683548 0.74 NR2E1 (0.40) NR2E1CYP1A2KDM4EMEN1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6844375-B2 4-methylene-1,3-dioxolanes as cross-linking agents DAINIPPON INK AND CHEMICALS, INC. (JP) 2005-01-18 US disclosed
EP-1182201-B1 4-Methylene-1,3-dioxolanes as cross-linking agents DAINIPPON INK & CHEMICALS (JP) 2004-11-24 EP disclosed
US-20020045674-A1 4-Methylene-1,3-dioxolanes as cross-linking agents DAINIPPON INK AND CHEMICALS, INC (JP) 2002-04-18 US disclosed
EP-1182201-A1 4-Methylene-1,3-dioxolanes as cross-linking agents DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045674-A1 4-Methylene-1,3-dioxolanes as cross-linking agents COL1A1, CCNA1, GJA1 NR2E1 841/4885CYP1A2 132/4885KDM4E 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.